Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2015

Open Access 01-12-2015 | Study protocol

Effectiveness of a transdiagnostic internet-based protocol for the treatment of emotional disorders versus treatment as usual in specialized care: study protocol for a randomized controlled trial

Authors: Alberto González-Robles, Azucena García-Palacios, Rosa Baños, Antonio Riera, Ginés Llorca, Francisco Traver, Gonzalo Haro, Vicente Palop, Guillem Lera, José Enrique Romeu, Cristina Botella

Published in: Trials | Issue 1/2015

Login to get access

Abstract

Background

Emotional disorders (depression and anxiety disorders) are highly prevalent mental health problems. Although evidence showing the effectiveness of disorder-specific treatments exists, high comorbidity rates among emotional disorders limit the utility of these protocols. This has led some researchers to focus their interest on transdiagnostic interventions, a treatment perspective that might be more widely effective across these disorders. Also, the current way of delivering treatments makes it difficult provide assistance to all of the population in need. The use of the Internet in the delivery of evidence-based treatments may help to disseminate treatments among the population. In this study, we aim to test the effectiveness of EmotionRegulation, a new transdiagnostic Internet-based protocol for unipolar mood disorders, five anxiety disorders (panic disorder, agoraphobia, social anxiety disorder, generalized anxiety disorder and anxiety disorder not otherwise specified), and obsessive-compulsive disorder in comparison to treatment as usual as provided in Spanish public specialized mental health care. We will also study its potential impact on basic temperament dimensions (neuroticism/behavioral inhibition and extraversion/behavioral activation). Expectations and opinions of patients about this protocol will also be studied.

Methods/Design

The study is a randomized controlled trial. 200 participants recruited in specialized care will be allocated to one of two treatment conditions: a) EmotionRegulation or b) treatment as usual. Primary outcome measures will be the BAI and the BDI-II. Secondary outcomes will include a specific measure of the principal disorder, and measures of neuroticism/behavioral inhibition and extraversion/behavioral activation. Patients will be assessed at baseline, post-treatment, and 3- and 12-month follow-ups. Intention to treat and per protocol analyses will be performed.

Discussion

Although the effectiveness of face-to-face transdiagnostic protocols has been investigated in previous studies, the number of published transdiagnostic Internet-based programs is still quite low. To our knowledge, this is the first randomized controlled trial studying the effectiveness of a transdiagnostic Internet-based treatment for several emotional disorders in public specialized care. Combining both a transdiagnostic approach with an Internet-based therapy format may help to decrease the burden of mental disorders, reducing the difficulties associated with disorder-specific treatments and facilitating access to people in need of treatment. Strengths and limitations are discussed.

Trial registration

ClinicalTrials.gov NCT02345668. Registered 27 July 2015.
Literature
1.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.PubMedCrossRef
2.
Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655–79.PubMedCrossRef
3.
Fehm L, Pelissolo A, Furmark T, Wittchen HU. Size and burden of social phobia in Europe. Eur Neuropsychopharmacol. 2005;15:453–62.PubMedCrossRef
4.
Hofmann SG, Heinrichs N, Moscovitch DA. The nature and expression of social phobia: toward a new classification. Clin Psychol Rev. 2004;24:769–97.PubMedCrossRef
5.
Craske MG, Roy-Byrne PP, Stein MB, Sullivan G, Sherbourne C, Bystritsky A. Treatment for anxiety disorders: efficacy to effectiveness to implementation. Behav Res Ther. 2009;47:931–7.PubMedCentralPubMedCrossRef
6.
Emmelkamp PMG, David D, Beckers T, Muris P, Cuijpers P, Lutz W, et al. Advancing psychotherapy and evidence-based psychological interventions. Int J Methods Psychiatr Res. 2014;23:58–91.PubMedCrossRef
7.
Stein MB, Roy-Byrne PP, Craske MG, Campbell-Sills L, Lang AJ, Golinelli D, et al. Quality of and patient satisfaction with primary health care for anxiety disorders. J Clin Psychiatry. 2011;72:970–6.PubMedCentralPubMedCrossRef
8.
Kazdin AE. Evidence-based psychotherapies I: Qualifiers and limitations in what we know. S Afr J Psychol. 2014;44:381–404.
9.
Bebbington PE, Meltzer H, Brugha TS, Farrell M, Jenkins R, Ceresa C, et al. Unequal access and unmet need: neurotic disorders and the use of primary care services. Psychol Med. 2000;30:1359–67.PubMedCrossRef
10.
Kazdin AE, Blase SL. Rebooting psychoteraphy research and practice to reduce the burden of mental illness. Perspect Psychol Sci. 2011;6:21–37.PubMedCrossRef
11.
Antony MM, Stein MB, editors. Oxford handbook of anxiety and related disorders. New York: Oxford University Press; 2009.
12.
Barlow DH. Anxiety and its disorders: The nature and treatment of anxiety and panic. 2nd ed. New York: Guilford Press; 2002.
13.
Cuijpers P, Smit F, Bohlmeijer E, Hollon ED, Andersson G. Efficacy of cognitive–behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias. Br J Psychiatry. 2010;196:173–8.PubMedCrossRef
14.
15.
Nathan PE, Gorman JM. A guide to treatments that work. 3rd ed. New York: Oxford University Press; 2007.
16.
Norton PJ, Price EP. A meta-analytic review of cognitive-behavioral treatment outcome across the anxiety disorders. J Nerv Ment Dis. 2007;195:521–31.PubMedCrossRef
17.
Olatunji BO, Cisler JM, Deacon BJ. Efficacy of cognitive behavioral therapy for anxiety disorders: a review of meta-analytic findings. Psychiatr Clin North Am. 2010;33:557–77.PubMedCrossRef
18.
Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol. 2001;110:585–99.PubMedCrossRef
19.
McManus F, Shafran R, Cooper Z. What does a transdiagnostic approach have to offer the treatment of anxiety disorders? Br J Clin Psychol. 2010;49:491–505.PubMedCrossRef
20.
Barlow DH, Allen LB, Choate ML. Toward a unified treatment for emotional disorders. Behav Therapy. 2004;35:205–30.CrossRef
21.
Clark DA, Taylor S. The transdiagnostic perspective on cognitive-behavioral therapy for anxiety and depression: new wine for old wineskins? J Cogn Psychother. 2009;23:60–6.CrossRef
22.
Norton PJ. An open trial of a transdiagnostic cognitive-behavioral group therapy for anxiety disorder. Behav Therapy. 2008;39:42–250.CrossRef
23.
Norton PJ, Hayes SA, Hope DA. Effects of a transdiagnostic group treatment for anxiety on secondary depression. Depress Anxiety. 2004;20:198–202.PubMedCrossRef
24.
Norton PJ, Barrera TL. Transdiagnostic versus diagnosis-specific CBT for anxiety disorders: a preliminary randomized controlled noninferiority trial. Depress Anxiety. 2012;29:874–82.PubMedCentralPubMedCrossRef
25.
Titov N, Andrews G, Johnston L, Robinson E, Spence J. Transdiagnostic Internet treatment for anxiety disorders: A randomized controlled trial. Behav Res Ther. 2010;48:890–9.PubMedCrossRef
26.
Carlbring P, Maurin L, Törngren C, Linna E, Eriksson T, Sparthan E, et al. Individually-tailored, Internet-based treatment for anxiety disorders: A randomized controlled trial. Behav Res Ther. 2011;49:18–24.PubMedCrossRef
27.
Roy-Byrne P, Craske MG, Sullivan G, Rose RD, Edlund MJ, Lang AJ, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. J Am Med Assoc. 2010;303:1921–8.CrossRef
28.
Dear BF, Titov N, Schwencke G, Andrews G, Johnston L, Craske MG, et al. An open trial of a brief transdiagnostic internet treatment for anxiety and depression. Behav Res Ther. 2011;49:830–7.PubMedCrossRef
29.
Titov N, Dear BF, Schwencke G, Andrews G, Johnston L, Craske MG, et al. Transdiagnostic internet treatment for anxiety and depression: a randomised controlled trial. Behav Res Ther. 2011;49:441–52.PubMedCrossRef
30.
Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Thompson-Hollands J, Carl JR, et al. Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behav Therapy. 2012;43:666–78.CrossRef
31.
Newby JM, McKinnon A, Kuyken W, Gilbody S, Dalgleish T. Systematic review and meta-analysis of transdiagnostic psychological treatments for anxiety and depressive disorders in adulthood. Clin Psychol Rev. 2015;40:91–110.PubMedCrossRef
32.
Reinholt N, Krogh J. Efficacy of transdiagnostic cognitive behaviour therapy for anxiety disorders: a systematic review and meta-analysis of published outcome studies. Cogn Behav Ther. 2014;43:171–84.PubMedCrossRef
33.
Brown T, Barlow D. A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: Implications for assessment. Psychol Assess. 2009;21:256–71.PubMedCentralPubMedCrossRef
34.
Barlow DH, Sauer-Zavala S, Carl JR, Bullis JR, Ellard KK. The nature, diagnosis, and treatment of neuroticism: back to the future. Clin Psychol Sci. 2013;2:344–65.CrossRef
35.
Barlow DH, Ellard KK, Sauer-Zavala S, Bullis JR, Carl JR. The origins of neuroticism. Perspect Psychol Sci. 2014;9:481–96.PubMedCrossRef
36.
Carl JR, Soskin DP, Kerns C, Barlow DH. Positive emotion regulation in emotional disorders: A theoretical review. Clin Psychol Rev. 2013;33:343–60.PubMedCrossRef
37.
Allen LB, McHugh RK, Barlow DH. Emotional disorders: A unified protocol. In: Barlow DH, editor. Clinical handbook of psychological disorders. 4th ed. New York: Guilford Press; 2008. p. 216–49.
38.
Ellard KK, Fairholme CP, Boisseau CL, Farchione TJ, Barlow DH. Unified protocol for the transdiagnostic treatment of emotional disorders: Protocol development and initial outcome data. Cogn Behav Pract. 2010;17:88–101.CrossRef
39.
Ehrenreich J, Goldstein C, Wright L, Barlow DH. Development of a unified protocol for the treatment of emotional disorders in youth. Child Family Behav Ther. 2009;31:20–37.CrossRef
40.
Boisseau CL, Farchione TJ, Fairholme CP, Ellard KK, Barlow DH. The development of the Unified protocol for the transdiagnostic treatment of emotional disorders: A case study. Cogn Behav Pract. 2010;17:88–101.CrossRef
41.
Wilamowska ZA, Thompson-Hollands J, Fairholme CP, Ellard KK, Farchione TJ, Barlow DH. Conceptual background, development, and preliminary data from the unified protocol for transdiagnostic treatment of emotional disorders. Depress Anxiety. 2010;27:882–90.PubMedCrossRef
42.
Bullis J, Fortune M, Farchione T, Barlow DH. A preliminary investigation of the long-term outcome of the unified protocol for transdiagnostic treatment of emotional disorders. Compr Psychiatry. 2014;55:1920–7.PubMedPubMedCentralCrossRef
43.
Gray JA, McNaughton N. The neuropsychology of anxiety: An enquiry into the functions of the septohippocampal system. 2nd ed. Oxford: Oxford University Press; 2000.
44.
Brown TA. Temporal course and structural relationships among dimensions of temperament and DSM-IV anxiety and mood disorder constructs. J Abnorm Psychol. 2007;116:313–28.PubMedCrossRef
45.
Gershuny B, Sher K. The relation between personality and anxiety: Findings from a 3-year prospective study. J Abnorm Psychol. 1998;107:252–62.PubMedCrossRef
46.
Kessler RC, Cox BJ, Green JG, Ormel J, McLaughlin KA, Merikangas KR, et al. The effects of latent variables in the development of comorbidity among common mental disorders. Depress Anxiety. 2011;28:29–39.PubMedCentralPubMedCrossRef
47.
Clark LA, Watson D. Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. J Abnorm Psychol. 1991;103:103–16.CrossRef
48.
Brown TA, Chorpita BF, Barlow DH. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. J Abnorm Psychol. 1998;107:179–92.PubMedCrossRef
49.
Rosellini AJ, Lawrence AE, Meyer JF, Brown TA. The effects of extraverted temperament on agoraphobia in panic disorder. J Abnorm Psychol. 2010;119:420–6.PubMedCentralPubMedCrossRef
50.
Kotov R, Gámez W, Schmidt F, Watson D. Linking “big” personality traits to anxiety, depressive, and substance use disorders: A meta- analysis. Psychol Bull. 2010;136:768–821.PubMedCrossRef
51.
Carl JR, Gallagher MW, Sauer-Zavala SE, Bentley KH, Barlow DH. A preliminary investigation of the effects of the unified protocol on temperament. Compr Psychiatry. 2014;55:1426–34.PubMedCentralPubMedCrossRef
52.
Linehan MM. Skills training manual for treating borderline personality disorder. Diagnosis and treatment of mental disorders. New York: Guilford Press; 1993.
53.
Neacsiu AD, Bohus M, Linehan MM. Dialectical behavior therapy: An intervention for emotion dysregulation. In: Gross JJ, editor. Handbook of emotion regulation. 2nd ed. New York: Guilford Press; 2014. p. 491–507.
54.
Ehring T, Tuschen-Caffier B, Schnülle J, Fischer S, Gross JJ. Emotion regulation and vulnerability to depression: Spontaneous versus instructed use of emotion suppression and reappraisal. Emotion. 2010;10:563–72.PubMedCrossRef
55.
Hayes SC, Strosahl K, Wilson KG, Bissett RT, Pistorello J, Toarmino D, et al. Measuring experiential avoidance: A preliminary test of a working model. Psychol Rec. 2004;54:553–78.
56.
Campbell-Sills L, Barlow DH, Brown TA, Hofmann SG. Acceptability and suppression of negative emotion in anxiety and mood disorders. Emotion. 2006;6:587–95.PubMedCrossRef
57.
Cisler JM, Olatunji BO, Feldner MT, Forsyth JP. Emotion regulation and the anxiety disorders: an integrative review. J Psychopathol Behav Assess. 2010;32:68–82.PubMedCentralPubMedCrossRef
58.
Kring AM, Bachorowski JA. Emotions and psychopathology. Cogn Emot. 1999;13:575–99.CrossRef
59.
Neacsiu AD, Eberle JW, Kramer R, Wiesmann T, Linehan MM. Dialectical behavior therapy skills for transdiagnostic emotion dysregulation: A pilot randomized controlled trial. Behav Res Ther. 2014;59:40–51.PubMedCrossRef
60.
Andersson G, Cuijpers P. Internet-based and other computerized psychological treatments for adult depression: A meta-analysis. Cogn Behav Ther. 2009;38:196–205.PubMedCrossRef
61.
Caspar F. Technological developments and applications in clinical psychology and psychotherapy: introduction. J Clin Psychol. 2004;60:221–38.PubMedCrossRef
62.
Clark DM, Layard R, Smithies R, Richards DA, Suckling R, Wright B. Improving access to psychological therapy: Initial evaluation of two UK demonstration sites. Behav Res Ther. 2009;47:910–20.PubMedCentralPubMedCrossRef
63.
Rochlen AB, Zack JS, Speyer C. Online therapy: review of relevant definitions, debates, and current empirical support. J Clin Psychol. 2004;60:269–83.PubMedCrossRef
64.
65.
Andrews G, Cuijpers P, Craske MG, McEvoy P, Titov N. Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PLoS One. 2010;5:e13196.PubMedCentralPubMedCrossRef
66.
Cuijpers P, van Straten A, Andersson G. Internet-administered cognitive behavior therapy for health problems: a systematic review. J Behav Med. 2008;31:169–77.PubMedCentralPubMedCrossRef
67.
Spek V, Cuijpers P, Nyklicek I, Keyzer J, Pop V. Internet-based cognitive behavior therapy for symptoms of depression and anxiety: A meta-analysis. Psychol Med. 2007;37:319–28.PubMedCrossRef
68.
Richards D, Richardson T. Computer-based psychological treatments for depression: a systematic review and meta-analysis. Clin Psychol Rev. 2012;32:329–42.PubMedCrossRef
69.
Titov N. Internet-delivered psychotherapy for depression in adults. Curr Opin Psychiatry. 2011;24:18–23.PubMedCrossRef
70.
Cuijpers P, Donker T, Johansson R, Mohr DC, van Straten A, Andersson G. Self-guided psychological treatment for depressive symptoms: A meta-analysis. PLoS One. 2011;6:1–7.CrossRef
71.
Bee PE, Bower P, Lovell K, Gilbody S, Richards D, Gask L, et al. Psychotherapy mediated by remote communication technologies: a meta-analytic review. BMC Psychiatry. 2008;8:60.PubMedCentralPubMedCrossRef
72.
Cuijpers P, van Straten A, Warmerdam L, Andersson G. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress Anxiety. 2009;26:279–88.PubMedCrossRef
73.
Berger T, Boettcher J, Caspar F. Internet-based guided self-help for several anxiety disorders: A randomized controlled trial comparing a tailored with a standardized disorder-specific approach. Psychother. 2014;51:207–19.CrossRef
74.
Andersson G, Estling F, Jakobsson E, Cuijpers P, Carlbring P. Can the patient decide which modules to endorse? An open trial of tailored Internet treatment of anxiety disorders. Cogn Behav Ther. 2011;40:57–64.PubMedCrossRef
75.
Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. J Am Podiatr Med Assoc. 2001;91:437–42.PubMedCrossRef
76.
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63:e1–37.PubMedCrossRef
77.
Eysenbach G, CONSORT-EHEALTH Group. CONSORT-EHEALTH: improving and standardizing evaluation reports of web-based and mobile health interventions. J Med Internet Res. 2011;13:e126.PubMedCentralPubMedCrossRef
78.
American Psychological Association. Diagnostic and statistical manual of mental disorders (4th ed. Rev.). Washington, DC: American Psychological Association; 2000.
79.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:34–57.
80.
Ferrando L, Bobes J, Gibert J, Lecubrier Y. Mini International Neuropsychiatric Interview. In: Bobes J, Bousoño M, González MP, editors. Manejo de los trastornos mentales y del comportamiento en Atención Primaria. 2nd ed. Oviedo: Gofer; 1997.
81.
Beck AT, Steer RA. Beck anxiety inventory manual. San Antonio: Psychological Corporation; 1993.
82.
Magán I, Sanz J, García-Vera MP. Psychometric properties of a Spanish version of the Beck Anxiety Inventory (BAI) in general population. Span J Psychol. 2008;11:626–40.PubMed
83.
Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation; 1990.
84.
Sanz J, Navarro ME, Vázquez C. Adaptación española del Inventario para la Depresión de Beck-II (BDI-II): 1. Propiedades psicométricas en estudiantes universitarios. Anal Mod Cond. 2003;29:239–88.
85.
Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther. 1998;36:455–70.PubMedCrossRef
86.
Zubeidat I, Salinas JM, Sierra JC, Fernández-Parra A. Psychometric properties of the Social Interaction Anxiety Scale and separation criterion between Spanish youths with and without subtypes of social anxiety. J Anxiety Disord. 2007;21:603–24.PubMedCrossRef
87.
Houck PR, Spiegel DA, Shear MK, Rucci P. Reliability of the self-report version of the panic disorder severity scale. Depress Anxiety. 2002;15:183–5.PubMedCrossRef
88.
Santacana M, Fullana MA, Bonillo A, Morales M, Montoro M, Rosado S, et al. Psychometric properties of the Spanish self-report version of the panic disorder severity scale. Compr Psychiatry. 2014;55:1467–72.PubMedCrossRef
89.
Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990;28:487–95.PubMedCrossRef
90.
Sandín B, Chorot P, Valiente RM, Lostao L. Validación española del cuestionario de preocupación PSWQ: Estructura factorial y propiedades psicométricas. Rev Psicopatol Psicol Clin. 2009;14:107–22.
91.
Foa EB, Huppert JD, Leiberg S, Langner R, Kichic R, Hajcak G, et al. The obsessive-compulsive inventory: development and validation of a short version. Psychol Assess. 2002;14:485–96.PubMedCrossRef
92.
Fullana MA, Tortella-Feliu M, Caseras X, Andión O, Torrubia R, Mataix-Cols D. Psychometric properties of the Spanish version of the obsessive-compulsive inventory-revised in a non-clinical sample. J Anxiety Disord. 2004;19:893–903.PubMedCrossRef
93.
Carver CS, White TL. Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: The BIS/ BAS scales. J Pers Soc Psychol. 1994;67:319–33.CrossRef
94.
Gray JA. The psychology of fear and stress. Cambridge: Cambridge University; 1987.
95.
Campbell-Sills L, Liverant GI, Brown TA. Psychometric evaluation of the behavioral inhibition/behavioral activation scales in a large sample of outpatients with anxiety and mood disorders. Psychol Assess. 2004;16:244–54.PubMedCrossRef
96.
Caseras X, Àvila C, Torrubia R. The measurement of individual differences in Behavioural Inhibition and Behavioural Activation Systems: a comparison of personality scales. Pers Individ Dif. 2003;34:999–1013.CrossRef
97.
Norman SB, Cissell SH, Means-Christensen AJ, Stein MB. Development and validation of an Overall Anxiety Severity and Impairment Scale (OASIS). Depress Anxiety. 2006;23:245–9.PubMedCrossRef
98.
Bentley KH, Gallagher MW, Carl JR, Barlow DH. Development and validation of the Overall Depression Severity and Impairment Scale. Psychol Assess. 2014;26:815–30.PubMedCrossRef
99.
Crawford JR, Henry JD. The Positive and Negative Affect Schedule (PANAS): Construct validity, measurement properties and normative data in a large non-clinical sample. Br J Clin Psychol. 2004;43:245–65.PubMedCrossRef
100.
Sandín B, Chorot P, Lostao L, Joiner TE, Santed MA, Valiente RM. Escalas Panas de afecto positivo y negativo: Validación factorial y convergencia transcultural. Psicothema. 1999;11:37–51.
101.
Badía X. EuroQol; un instrumento para valorar la salud EQ-5D guía del usuario, versión española. Med Clin (Barc). 1999;114:6–14.
102.
Badía X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin. 1999;112:79–85.
103.
Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry. 1972;3:257–60.CrossRef
104.
Botella C, Gallego MJ, Garcia-Palacios A, Baños RM, Quero S, Alcañiz M. The acceptability of an Internet-based self-help treatment for fear of public speaking. Br J Guid Couns. 2009;37:297–311.CrossRef
105.
Botella C, García-Palacios A, Villa H, Baños RM, Quero S, Alcañiz M, et al. Virtual reality exposure in the treatment of panic disorder and agoraphobia: A controlled study. Clin Psychol Psychother. 2007;14:164–75.CrossRef
106.
Watts SE, Turnell A, Kladnitski N, Newby JM, Andrews G. Treatment-as-usual (TAU) is anything but usual: A meta-analysis of CBT versus TAU for anxiety and depression. J Affect Disord. 2015;175:152–67.PubMedCrossRef
107.
Johansson R, Andersson G. Internet-based psychological treatments for depression. Expert Rev Neurother. 2012;12:861–70.PubMedCrossRef
108.
Van Ballegooijen W, Cuijpers P, van Straten A, Karyotaki E, Andersson G, Smit JH, et al. Adherence to internet-based and face-to-face cognitive behavioural therapy for depression: a meta-analysis. PLoS One. 2014;9:e100674.PubMedCentralPubMedCrossRef
109.
Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated- measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry. 2004;61:310–7.PubMedCrossRef
110.
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Erlbaum; 1988.
111.
Wright CC, Sim J. Intention-to-treat approach to data from randomized controlled trials: A sensitivity analysis. J Clin Epidemiol. 2003;56:833–42.PubMedCrossRef
Metadata
Title
Effectiveness of a transdiagnostic internet-based protocol for the treatment of emotional disorders versus treatment as usual in specialized care: study protocol for a randomized controlled trial
Authors
Alberto González-Robles
Azucena García-Palacios
Rosa Baños
Antonio Riera
Ginés Llorca
Francisco Traver
Gonzalo Haro
Vicente Palop
Guillem Lera
José Enrique Romeu
Cristina Botella
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Trials / Issue 1/2015
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-015-1024-3

Other articles of this Issue 1/2015

Trials 1/2015 Go to the issue

Study protocol

Osteopathic manipulative treatment and pain in preterms: study protocol for a randomised controlled trial

Study protocol

Evaluation of the effectiveness of photodynamic therapy for the endodontic treatment of primary teeth: study protocol for a randomized controlled clinical trial

Study protocol

A pilot feasibility, safety and biological efficacy multicentre trial of therapeutic hypercapnia after cardiac arrest: study protocol for a randomized controlled trial

Study protocol

The acute effect of beta-guanidinopropionic acid versus creatine or placebo in healthy men (ABC Trial): study protocol for a randomized controlled trial

Study protocol

Faecal incontinence intervention study (FINS): self-management booklet information with or without nurse support to improve continence in people with inflammatory bowel disease: study protocol for a randomized controlled trial

Study protocol

Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial